Novel adenosine derivatives and pharmaceutical composition conta

Details Novel adenosine derivatives and pharmaceutical composition conta Novel adenosine derivatives and pharmaceutical composition conta

1987-11-20

1989-06-27

Griffin, Ronald W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514 46, 536 24, 536 26, A61K 3170, C07H 1916

Patent

active

048430668

ABSTRACT:
Novel adenosine compounds of the formula (I): ##STR1## wherein R.sub.1, R.sub.2 and R.sub.3 are hydrogen or a lower alkyl group; X is hydrogen, a lower alkyl group, an amino group or halogen; and Y is hydrogen or a lower alkyl group, exhibit utility as antihypertensive agents.

REFERENCES:
patent: 3248380 (1966-08-01), Moffatt et al.
patent: 3590029 (1971-06-01), Koch et al.
patent: 3819612 (1974-06-01), Imai et al.
Kochetkov et al., Organic Chemistry of Nucleic Acids, Part B, Plenum Press, N.Y., N.Y., 1972, pp. 459-460.

Affiliated with

Also associated with

Rating

Novel adenosine derivatives and pharmaceutical composition conta does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel adenosine derivatives and pharmaceutical composition conta, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel adenosine derivatives and pharmaceutical composition conta will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-813851